Memorial Sloan Kettering Cancer Center
A 100% response rate suggests dostarlimab is ‘definitive’ therapy for rectal cancer
CHICAGO — A phase 2 study evaluating dostarlimab in adults with mismatch repair-deficient locally advanced rectal cancer has maintained a 100% clinical complete response rate at a median follow-up of almost 18 months.
Findings highlight need to improve prior authorization process for cancer pain management
CHICAGO — A review of more than 1,700 prior authorization requests related to pain medication for people with cancer showed the vast majority ultimately got approved.
Patient-reported outcomes leveraged to overcome barriers to clinical trial enrollment
Participation in cancer-related clinical trials could increase dramatically if researchers screened and recruited individuals using routine care patient-reported outcomes, according to results published in JAMA Oncology.
Invisible ink for radiation may improve patient quality of life
A novel invisible ink tattoo technique may improve long-term quality of life and emotional well-being for people with cancer who undergo radiation therapy, according to study results.
AI tool shows ‘clinically significant impact’ on completion of cancer screening
Researchers at Montefiore Einstein Comprehensive Cancer Center have developed an AI-based patient navigation tool that may increase completion of colonoscopies among individuals who canceled or did not show for an initial appointment.
Study reveals 'consistent association' between genital talc, ovarian cancer
Genital talc powder use increased risk for ovarian cancer in cohort of women, according to study results published in Journal of Clinical Oncology.
HSCT for older patients with MDS: Seizing the window of opportunity for high-risk patients
Myelodysplastic syndrome predominantly affects older adults, with median age of onset of 70 years.
Cryoablation could freeze recurrence in its tracks for patients with breast cancer
Yolanda Bryce, MD, still remembers her patient’s shock.
Physical quality of life after axillary lymph node dissection impacted by race, insurance
Black, Hispanic and Asian women reported more arm swelling after axillary lymph node dissection for breast cancer compared with white women, according to findings published in JAMA Surgery.
Guidelines: Toxicity management vital with tumor-infiltrating lymphocytes
Clinicians treating patients with tumor-infiltrating lymphocytes should closely monitor toxicities associated with interleukin-2 and halt administration of the drug if necessary, according to the first guidelines regarding the therapy.